Pemfexy
Term · Oncology and biomedicine · MLC-T-ONC-006471
A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. Pemfexy stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called Alimta, LY231514, and pemetrexed disodium.
| Identifier | MLC-T-ONC-006471 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Alimta; LY231514; pemetrexed disodium |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006471",
"term": "Pemfexy",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. Pemfexy stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called Alimta, LY231514, and pemetrexed disodium.",
"synonyms": [
"Alimta",
"LY231514",
"pemetrexed disodium"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/pemfexy/"
}
Record 12,900 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.